BamSEC and AlphaSense Join Forces
Learn More

ACORDA THERAP.NEW DL-001

OTC: CDG:MU    
Share price (10/14/24): $0.79    
Market cap (10/14/24): $975 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.49
from 10-K 31 pages Restructuring Support Agreement Recitals
12/34/56
EX-10.48
from 10-K 107 pages Asset Purchase Agreement by and Among Acorda Therapeutics, Inc., Civitas Therapeutics, Inc., Merz Pharmaceuticals, LLC and Merz Pharma Gmbh & Co. Kgaa (Solely for the Purposes Set Forth Herein) Dated as of March 31, 2024
12/34/56
EX-10.21
from 10-K 4 pages March 26, 2024 [ ] [Address] [City, State, Zip Code] Re: Amendment to Letter Agreement
12/34/56
EX-10
from 10-K 3 pages Material contract
12/34/56
EX-10
from 10-K 3 pages First Amendment to Manufacturing Services Agreement
12/34/56
EX-10
from 10-K 55 pages Between Catalent Massachusetts LLC and Acorda Therapeutics, Inc. Effective Date: January 1, 2023
12/34/56
EX-10
from 10-K 7 pages Settlement and Release Agreement
12/34/56
EX-10
from 10-K 36 pages Article 7 19 Co-Operation 19 7.1 Quarterly Review. 19 Acorda: 19 Patheon: 19 7.2 Governmental Agencies. 20 7.3 Records and Accounting by Patheon. 20 7.4 Inspection. 20 7.5 Access. 20 7.6 Notification of Regulatory Inspections. 20 7.7 Reports. 20 7.8 FDA Filings 20 Article 8 21 Term and Termination 21 8.1 Term. 21 8.2 Termination for Cause. 21 8.3 Product Discontinuation. 22 8.4 Obligations on Termination. 22 Article 9 23 Representations, Warranties and Covenants 23 9.1 Authority. 23 9.2 Client Warranties. 23 9.3 Patheon Warranties. 24 9.4 Debarred Persons. 24 9.5 Permits. 25 9.6 No Warranty. 25
12/34/56
EX-10.5
from 10-Q 8 pages June 2, 2022 Neil S. Belloff [Address] [City, State, Zip Code] 1. Employment. You Will Be Employed by the Company as Its General Counsel. 2. Base Salary
12/34/56
EX-10.4
from 10-Q 8 pages June 2, 2022 Michael A. Gesser [Address] [City, State, Zip Code] 1. Employment. You Will Be Employed by the Company as Its Chief Financial Officer. 2. Base Salary
12/34/56
EX-10.3
from 10-Q 8 pages June 2, 2022 1. Employment. You Will Continue to Be Employed by the Company as Its Chief Commercial Officer. 2. Base Salary
12/34/56
EX-10.2
from 10-Q 8 pages June 2, 2022 Lauren Sabella [Address] [City, State, Zip Code] 1. Employment. You Will Continue to Be Employed by the Company as Chief Operating Officer. 2. Base Salary
12/34/56
EX-10.52
from 10-K 3 pages Second Amendment to Manufacturing Services Agreement
12/34/56
EX-10.51
from 10-K 4 pages First Amendment to Manufacturing Services Agreement
12/34/56
EX-10.28
from 10-K 3 pages November 4, 2021 1. the Salary Is $450,000.00 Per Annum, Payable Semi-Monthly on the 15th and the Last Business Day of the Month. the Semi-Monthly Rate Is $18,750.00. 2. Your Start Date Is November 8, 2021. 3. as of the Start Date, You Will Be Eligible to Participate in Acorda’s Benefit Plans, Flexible Spending Accounts and the Company’s 401(k) Plan
12/34/56
EX-10.27
from 10-K 3 pages November 4, 2021 1. the Salary Is $450,000.00 Per Annum, Payable Semi-Monthly on the 15th and the Last Business Day of the Month. the Semi-Monthly Rate Is $18,750.00. 2. Your Start Date Is November 8, 2021. 3. as of the Start Date, You Will Be Eligible to Participate in Acorda’s Benefit Plans, Flexible Spending Accounts and the Company’s 401(k) Plan. 4. You Will Be Reimbursed for Reasonable Expenses Incurred With Your Travel to Ardsley Including Hotel and Car Rental
12/34/56
EX-10.25
from 10-K 13 pages Master Consulting Agreement
12/34/56
EX-10.24
from 10-K 12 pages December 31, 2021 Burkhard Blank [Address] [City, State, Zip Code] Re:separation Agreement and General Release
12/34/56
EX-10.21
from 10-K 2 pages Sabella Employment Agreement Amendment
12/34/56
EX-10.11
from 10-K 4 pages Acorda Therapeutics, Inc. 2016 Inducement Plan Non-Statutory Stock Option Certificate
12/34/56